James Wemett, NaturalNano CEO, said "We are pleased that Dr. King's lab continues to experience success with NNAN’s HNT. Dr. King's work continues to expand our understanding of the potential role that HNT may play in life science applications."
Other guest speakers attending are from Roche, Pfizer, and Genentech.
// DrugSense Drug War Clock